https://www.clinicaltrialsarena.com/news/newsuniversity-of-miami-reports-positive-phase-ii-trial-result-of-arimoclomol-to-treat-als-5693531/
University of Miami reports positive Phase II trial result of arimoclomol to treat ALS - Clinical...
Dec 12, 2016 - University of Miami Miller School of Medicine has reported positive data from its Phase II trial of arimoclomol to treat amyotrophic lateral sclerosis (ALS).
university of miamiphase iireportspositivetrial